KEY HIGHLIGHTS Results CSPC Pharmaceutical Group (1093 HK/BUY/HK$8.35/Target: HK$11.00) 2022: Adjusted earnings up 12.7% yoy; expects positive revenue and earnings growth in 2023. Jiumaojiu International Holdings (9922 HK/BUY/HK$18.88/Target: HK$22.20) 2022: Results in line; Tai Er enters stability and Song Hotpot expands. Minth Group (425 HK/BUY/HK$18.98/Target: HK$27.00) 2H22: Net profit up 42% yoy and 28% hoh, missing estimates. Trim target price from HK$30.00 to HK$27.00. Maintain BUY. T...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.